Options data reveal where Intel stock will be trading after earnings on Jan 22
Intel (NASDAQ: INTC) sure had a blockbuster 2025 but options traders seem to believe the stock could push higher still as the…
Gold, silver at record highs: analysts predict further upside as geopolitical risks persist
Gold and silver soared to record highs on Monday as a result of a flight to safety, triggered after US President Donald…
Why analysts are not impressed with Trump’s ‘Great Healthcare Plan’
The Trump administration on Thursday unveiled what it called the “Great Healthcare Plan,” a broad framework aimed at addressing healthcare affordability, drug…
Why CEOs and CISOs are split on AI-driven cyber risk
Artificial intelligence is reshaping cybersecurity faster than many companies can adjust their defences. It is helping organisations spot threats earlier, automate responses,…
Netflix earnings preview: investors watch ads, churn and Warner Bros. deal
Netflix is preparing to report its fourth-quarter fiscal 2025 earnings after the market closes on Tuesday, January 20, with investors focused on…
Easing Iran tensions erase oil’s risk premium, but analysts warn volatility ahead
Oil prices face mounting fundamental pressure as potential shifts in global oversupply dynamics emerge, driven by China’s decelerating stockpiling, which is tied…
Top 3 reasons to sell AST SpaceMobile stock as it soars on new SHIELD contract
AST SpaceMobile (NASDAQ: ASTS) pushed meaningfully higher to print a record high of nearly $120 this morning after being picked as a…
Evening digest: Trump threatens Greenland tariffs, backs Venezuela’s Rodríguez, Canada resets China trade
Tonight’s digest tracks the accelerating use of trade and tariffs as geopolitical leverage, from Trump’s renewed pressure campaign over Greenland to Canada’s…
US midday market brief: S&P 500 edges up, but losses loom after Trump’s Fed comments
US stocks ticked higher at midday Friday as the S&P 500 climbed 0.3%, the Nasdaq advanced 0.4%, and the Dow Jones Industrial…
How weight-loss drugs are destroying big snacking, erasing billions in sales
“GLP-1 drugs don’t just change what people eat,” Karthik Srinivasan, communications strategy consultant, tells Invezz. They change whether people want to eat…
